Medical Marijuana Card Does Not Excuse a Positive DOT Drug Test
DEA rescheduling hearing continues, but DOT already clarified that state medical-marijuana authorization cannot override a positive test result for commercial drivers.
Does a medical marijuana card let a driver pass a DOT drug test?
No. A medical marijuana card, doctor's recommendation, or dispensary receipt does not give a medical review officer grounds to report a positive DOT marijuana test as negative. The Department of Transportation clarified that position earlier this year after federal officials reclassified certain medical-marijuana products.
A state medical-marijuana authorization still cannot excuse a positive DOT marijuana test. That rule applies to every commercial driver holding a CDL, regardless of state law.
DEA rescheduling hearing adds GAO report to evidence
On October 22, Drug Enforcement Administration Chief Administrative Law Judge Derek Julius agreed to add a Government Accountability Office report to the evidence being considered in the marijuana rescheduling hearing. The report examined gaps in how federal agencies document and carry out drug-scheduling decisions.
The judge declined to reopen the hearing for more testimony. Instead, he gave the parties additional time to submit written arguments about the report, with final replies due November 5.
That is a filing deadline, not a decision date on rescheduling. The hearing record remains open for written submissions, but no new oral testimony will be taken.
What the DOT clarification means for carriers and drivers
Carriers cannot accept a medical marijuana card as documentation that clears a driver to return to duty after a positive test. The medical review officer must report the test as positive. The driver enters the Drug and Alcohol Clearinghouse as a prohibited driver until completing the return-to-duty process with a substance-abuse professional.
A driver who tests positive for marijuana cannot argue that a state medical-marijuana program authorized the use. DOT drug-testing regulations apply nationwide and supersede state law for safety-sensitive positions. A positive marijuana test disqualifies the driver from operating a commercial motor vehicle until the return-to-duty requirements are met.
Fleets that allow a driver to continue operating after a positive marijuana test face enforcement action from FMCSA. The carrier must immediately remove the driver from safety-sensitive functions. The driver cannot return until a substance-abuse professional evaluates them, they complete any recommended treatment, and they pass a return-to-duty test.
Federal reclassification did not change DOT testing rules
Earlier this year, federal officials reclassified certain medical-marijuana products. That reclassification did not change DOT drug-testing requirements for commercial drivers. DOT issued a clarification to prevent confusion among carriers and medical review officers.
The clarification reinforced existing policy. A positive marijuana test is a positive marijuana test under DOT regulations, regardless of whether the driver holds a state medical-marijuana card or whether the product is federally reclassified. The five-panel DOT drug screen includes marijuana. A confirmed positive result for marijuana triggers the same consequences as a positive result for any other tested substance.
Carriers should update their drug and alcohol policy handbooks to include the DOT clarification. Drivers need to understand that state medical-marijuana authorization does not protect them from DOT testing consequences. A driver who uses marijuana, even with a state card, risks a positive test and immediate disqualification.
Rescheduling hearing does not affect current DOT rules
The DEA rescheduling hearing addresses how marijuana is classified under the Controlled Substances Act. That classification affects criminal penalties, research access, and federal enforcement priorities. It does not directly change DOT drug-testing regulations for commercial drivers.
DOT maintains separate authority over safety-sensitive transportation workers. Even if DEA rescheduled marijuana to a lower classification, DOT would need to issue a separate rulemaking to change the drug-testing panel or the consequences of a positive marijuana test. No such rulemaking is underway.
Carriers should not assume that a DEA rescheduling decision will change DOT testing rules. Until DOT issues a final rule removing marijuana from the five-panel screen or changing the consequences of a positive test, current regulations remain in effect. A positive marijuana test still disqualifies a driver.
What to tell drivers about marijuana and DOT testing
Carriers should communicate three points to drivers:
- A medical marijuana card does not excuse a positive DOT drug test. The medical review officer will report the test as positive.
- A positive marijuana test disqualifies the driver immediately. The driver cannot operate a commercial motor vehicle until completing the return-to-duty process.
- State marijuana laws do not override DOT drug-testing regulations. Federal rules apply to all commercial drivers, regardless of state law.
Fleets that hire drivers in states with medical or recreational marijuana programs face higher risk of positive tests. Pre-employment screening and random testing will catch drivers who use marijuana, even if state law permits it. Carriers should budget for the cost of replacing drivers who test positive and for the administrative burden of managing Clearinghouse entries.
The DOT clarification eliminates any ambiguity. A medical marijuana card is not a defense to a positive test. Carriers that accept a card as documentation risk enforcement action. Medical review officers who report a positive marijuana test as negative based on a state card violate DOT regulations.
